A Costa Rican company just went public and is set to disrupt an outdated breast implant industry (ESTA)

Spencer Platt/Getty

• Costa Rica-based company Establishment Labs, the maker of Motiva breast implants, went public last week.
• It was the first IPO for the aesthetics sector in 2018, and the first breast aesthetics public offering in more than three years.
• The company is trying to disrupt an industry dominated by just three players: J&J, Allergan, and Sientra.
• The funding from the initial public offering will help the company advance through FDA clinical trials. 

Breast augmentation surgeries are the most popular plastic surgery procedures in the world, but there has been little innovation in years.

A Costa-Rican company called Establishment Labs hopes to change that by bringing an updated breast implant into the US market.

See the rest of the story at Business Insider

NOW WATCH: NYU Stern professor on what many people get wrong about sustainability: It’s not just about the environment and it actually leads to better financial performance

See Also:

• One Medical, a fast-growing startup that’s trying to reinvent how you visit your doctor, is betting it can ‘blow this thing out nationally’
• 10 pharmacy startups that could be M&A targets after Amazon’s acquisition of PillPack
• The billion-dollar healthcare unicorns you should be watching in 2018

SEE ALSO: Sunscreen doesn’t always shield beachgoers from burns — and so these scientists set out to make it work better